3 days of β-lactam therapy is non-inferior to 8 days of therapy among patients...
1. Cure at 15 days occurred in 77% of patients in the placebo (3-day therapy) group compared to 68% of patients in the β-lactam...
Reinfection rates among patients previously testing positive for COVID-19
1. Among a large U.S. cohort, previous infection with SARS-CoV-2 appears to confer high levels of immunity against reinfection for at least 8 months.
Evidence...
4PEPS clinical probability score may reduce need for imaging in suspected pulmonary embolism
1. The 4PEPs strategy (4-Level Pulmonary Embolism Clinical Probability Score) may be a useful tool for emergency department physicians in patients suspected of pulmonary...
Sex differences in ischemic stroke outcomes in patients with pulmonary hypertension
1. Pulmonary hypertension (PH) was associated with a 15% increase in odds of prolonged hospitalization.
2. PH was associated with a 31% decrease in odds...
Attributes and predictors of long COVID
1. Those testing positive for COVID-19 and experiencing five or more symptoms during the first week had greater odds of having a symptom duration...
Everolimus treatment effective for improving renal function in lung transplant patients
1. Lung transplant patients showed improved renal function and reduced immunosuppressant dosage after twelve months of everolimus treatment.
2. Patients with chronic lung allograft dysfunction...
Polypharmacy in non-care home residents strongly associated with higher rates of severe COVID-19
1. Polypharmacy in non-care home residents was strongly associated with higher rates of severe COVID-19.
Evidence Rating Level: 3 (Average)
Resistant hypertension, which is uncontrolled despite...
Higher SARS-CoV-2 infection rate in pregnant patients
1. In Washington State, pregnant patients were found to be at a higher risk of SARS-CoV-2 infection.
2. Results were more pronounced if patients belonged...
Cemiplimab monotherapy significantly improves outcomes in patients with advanced non-small-cell lung cancer with PD-L1...
1. Median overall survival and progression-free survival were significantly improved with cemiplimab monotherapy compared to chemotherapy.
2. Patients treated with cemiplimab monotherapy reported fewer grade...
Pulmonary arterial pruning and longitudinal change in percent emphysema and lung function
1. Among patients with and without COPD, a greater magnitude of pulmonary arterial pruning as measured by CT imaging was associated with a faster...
